OLMA Olema Pharmaceuticals, Inc.
Healthcare · Market cap: $661.5M
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $0 | $60.9K |
| 2022-Q2 | $806.0K | $0 |
| 2022-Q3 | $0 | $0 |
| 2022-Q4 | $0 | $0 |
| 2023-Q1 | $0 | $0 |
| 2023-Q2 | $0 | $124.8K |
| 2023-Q3 | $19.8M | $972.4K |
| 2023-Q4 | $3.0M | $2.8M |
| 2024-Q1 | $0 | $913.3K |
| 2024-Q2 | $0 | $18.1M |
| 2024-Q3 | $0 | $35.9M |
| 2024-Q4 | $4.7M | $11.4M |
| 2025-Q1 | $1.7M | $0 |
| 2025-Q2 | $0 | $0 |
| 2025-Q3 | $0 | $204.8K |
| 2025-Q4 | $0 | $17.0M |
| 2026-Q1 | $0 | $7.4M |
| 2026-Q2 | $0 | $0 |
| 2026-Q3 | $0 | $291.2K |
| 2026-Q4 | $0 | $0 |
Bought$37.1M8 buy days
Sold$95.5M77 sell days
Net insider flow-$58.4Mnet selling · 5 years
Latest trade2026-07-24Harmon Cyrus
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2026-07-24 | Sell | Harmon Cyrus | Director | 12,500 | $11.71 | $146.4K | 1 |
| 2026-07-23 | Sell | Harmon Cyrus | Director | 12,500 | $11.58 | $144.7K | 1 |
| 2026-03-04 | Sell | Mitchell Shawnte | Other C-suite | 25,000 | $24.25 | $606.4K | 2 |
| 2026-03-03 | Sell | Mitchell Shawnte | Other C-suite | 15,000 | $23.01 | $345.2K | 1 |
| 2026-01-20 | Sell | Harmon Cyrus | Director | 10,000 | $26.88 | $268.8K | 1 |
| 2026-01-15 | Sell | Kovacs Shane William Charles | Other officer | 100,000 | $28.73 | $2.9M | 1 |
| 2026-01-14 | Sell | Myles David C. | Other officer | 50,000 | $28.87 | $1.4M | 2 |
| 2026-01-14 | Sell | Harmon Cyrus | Director | 3,489 | $29.12 | $101.6K | 1 |
| 2026-01-13 | Sell | Myles David C. | Other officer | 50,000 | $27.60 | $1.4M | 2 |
| 2026-01-13 | Sell | Kovacs Shane William Charles | Other officer | 3,822 | $28.01 | $107.1K | 1 |
| 2026-01-12 | Sell | Myles David C. | Other officer | 10,000 | $28.34 | $283.4K | 1 |
| 2025-12-23 | Sell | Zojwalla Naseem | Other C-suite | 99,509 | $27.66 | $2.8M | 1 |
| 2025-12-22 | Sell | Zojwalla Naseem | Other C-suite | 100,000 | $28.04 | $2.8M | 1 |
| 2025-12-22 | Sell | Harmon Cyrus | Director | 2,881 | $28.53 | $82.2K | 1 |
| 2025-12-19 | Sell | CLARK IAN T | Director | 264,800 | $29.73 | $7.9M | 3 |
| 2025-12-19 | Sell | Zojwalla Naseem | Other C-suite | 70,000 | $28.20 | $2.0M | 2 |
| 2025-12-19 | Sell | Myles David C. | Other officer | 51,000 | $30.46 | $1.6M | 3 |
| 2025-09-18 | Sell | Harmon Cyrus | Director | 13,086 | $8.33 | $109.0K | 2 |
| 2025-09-16 | Sell | Harmon Cyrus | Director | 11,914 | $8.05 | $95.9K | 2 |
| 2025-01-08 | Buy | Bain Capital Life Sciences Investors, LLC | 10% owner | 300,000 | $5.76 | $1.7M | 1 |
| 2024-12-17 | Sell | Graham G. Walmsley | Director | 700,761 | $6.75 | $4.7M | 1 |
| 2024-12-13 | Sell | Graham G. Walmsley | Director | 700,761 | $6.75 | $4.7M | 1 |
| 2024-12-13 | Buy | Graham G. Walmsley | Director | 700,761 | $6.75 | $4.7M | 1 |
| 2024-12-11 | Sell | Bohen Sean | CEO | 57,174 | $8.68 | $496.1K | 2 |
| 2024-12-11 | Sell | Kovacs Shane William Charles | Other officer | 18,356 | $8.68 | $159.3K | 2 |
| 2024-12-11 | Sell | Zojwalla Naseem | Other C-suite | 14,522 | $8.68 | $126.0K | 2 |
| 2024-12-11 | Sell | Myles David C. | Other officer | 13,614 | $8.68 | $118.1K | 2 |
| 2024-12-11 | Sell | Harmon Cyrus | Director | 8,137 | $8.68 | $70.6K | 2 |
| 2024-12-10 | Sell | Bohen Sean | CEO | 52,328 | $9.37 | $490.3K | 1 |
| 2024-12-10 | Sell | Kovacs Shane William Charles | Other officer | 16,803 | $9.37 | $157.4K | 1 |
| 2024-12-10 | Sell | Zojwalla Naseem | Other C-suite | 13,283 | $9.37 | $124.5K | 1 |
| 2024-12-10 | Sell | Myles David C. | Other officer | 12,452 | $9.38 | $116.8K | 1 |
| 2024-12-10 | Sell | Harmon Cyrus | Director | 8,256 | $9.37 | $77.4K | 1 |
| 2024-08-01 | Sell | Paradigm BioCapital International Fund Ltd. | 10% owner | 2,400,000 | $14.92 | $35.8M | 2 |
| 2024-07-30 | Sell | Harmon Cyrus | Director | 934 | $15.55 | $14.5K | 1 |
| 2024-07-29 | Sell | Harmon Cyrus | Director | 4,066 | $15.58 | $63.3K | 1 |
| 2024-07-11 | Sell | Harmon Cyrus | Director | 5,000 | $12.26 | $61.3K | 1 |
| 2024-06-28 | Sell | Harmon Cyrus | Director | 20,000 | $10.77 | $215.4K | 1 |
| 2024-06-04 | Sell | Graham G. Walmsley | Director | 1,175,000 | $14.85 | $17.4M | 2 |
| 2024-06-04 | Sell | Harmon Cyrus | Director | 5,000 | $12.33 | $61.6K | 1 |
| 2024-06-03 | Sell | Harmon Cyrus | Director | 5,000 | $10.93 | $54.6K | 1 |
| 2024-05-31 | Sell | Harmon Cyrus | Director | 15,000 | $9.41 | $141.2K | 1 |
| 2024-05-06 | Sell | Harmon Cyrus | Director | 5,000 | $10.92 | $54.6K | 1 |
| 2024-04-30 | Sell | Harmon Cyrus | Director | 15,000 | $9.51 | $142.6K | 1 |
| 2024-03-28 | Sell | Harmon Cyrus | Director | 20,000 | $10.97 | $219.4K | 1 |
| 2024-02-29 | Sell | Harmon Cyrus | Director | 25,000 | $12.41 | $310.3K | 2 |
| 2024-02-01 | Sell | Harmon Cyrus | Director | 5,000 | $15.56 | $77.8K | 1 |
| 2024-01-31 | Sell | Harmon Cyrus | Director | 25,000 | $12.23 | $305.8K | 1 |
| 2023-12-29 | Sell | Harmon Cyrus | Director | 25,000 | $13.38 | $334.5K | 2 |
| 2023-12-06 | Buy | Paradigm BioCapital International Fund Ltd. | 10% owner | 100,000 | $11.60 | $1.2M | 1 |
| 2023-12-05 | Buy | Graham G. Walmsley | Director | 131,870 | $14.19 | $1.9M | 3 |
| 2023-11-30 | Sell | Harmon Cyrus | Director | 25,000 | $12.57 | $314.2K | 1 |
| 2023-11-22 | Sell | Bohen Sean | CEO | 27,932 | $13.90 | $388.3K | 1 |
| 2023-11-22 | Sell | Kovacs Shane William Charles | Other officer | 9,145 | $13.89 | $127.0K | 1 |
| 2023-11-22 | Sell | Zojwalla Naseem | Other C-suite | 7,095 | $13.89 | $98.5K | 1 |
| 2023-11-22 | Sell | Myles David C. | Other officer | 6,653 | $13.89 | $92.4K | 1 |
| 2023-11-22 | Sell | Harmon Cyrus | Director | 3,989 | $13.90 | $55.4K | 1 |
| 2023-11-21 | Sell | Bohen Sean | CEO | 29,293 | $14.88 | $435.9K | 2 |
| 2023-11-21 | Sell | Kovacs Shane William Charles | Other officer | 9,597 | $14.86 | $142.6K | 2 |
| 2023-11-21 | Sell | Zojwalla Naseem | Other C-suite | 7,461 | $14.84 | $110.7K | 2 |
| 2023-11-21 | Sell | Myles David C. | Other officer | 6,976 | $14.88 | $103.8K | 2 |
| 2023-11-21 | Sell | Harmon Cyrus | Director | 4,192 | $14.86 | $62.3K | 1 |
| 2023-11-08 | Sell | Myles David C. | Other officer | 200 | $17.61 | $3.5K | 1 |
| 2023-11-03 | Sell | Myles David C. | Other officer | 541 | $17.51 | $9.5K | 1 |
| 2023-11-02 | Sell | Harmon Cyrus | Director | 5,000 | $15.64 | $78.2K | 1 |
| 2023-11-02 | Sell | Myles David C. | Other officer | 3,332 | $15.36 | $51.2K | 1 |
| 2023-11-01 | Sell | Myles David C. | Other officer | 6,668 | $15.02 | $100.2K | 1 |
| 2023-10-31 | Sell | Harmon Cyrus | Director | 25,000 | $12.05 | $301.2K | 1 |
| 2023-09-29 | Sell | Harmon Cyrus | Director | 25,000 | $12.41 | $310.2K | 1 |
| 2023-09-19 | Sell | Myles David C. | Other officer | 20,000 | $12.67 | $253.4K | 1 |
| 2023-09-12 | Buy | LAMPERT MARK N | Director | 1,505,932 | $9.84 | $14.8M | 3 |
| 2023-09-12 | Buy | Graham G. Walmsley | Director | 508,130 | $9.84 | $5.0M | 1 |
| 2023-09-05 | Sell | Harmon Cyrus | Director | 10,000 | $11.62 | $116.2K | 1 |
| 2023-08-31 | Sell | Harmon Cyrus | Director | 15,000 | $9.36 | $140.4K | 1 |
| 2023-08-16 | Sell | Harmon Cyrus | Director | 15,000 | $10.14 | $152.1K | 1 |
| 2023-06-08 | Sell | Harmon Cyrus | Director | 10,000 | $6.30 | $63.0K | 1 |
| 2023-06-06 | Sell | Harmon Cyrus | Director | 5,000 | $6.30 | $31.5K | 1 |
| 2023-06-05 | Sell | Harmon Cyrus | Director | 5,000 | $6.05 | $30.2K | 1 |
| 2022-06-10 | Buy | LAMPERT MARK N | Director | 200,000 | $4.03 | $806.0K | 2 |
| 2022-03-10 | Sell | Horn Kinney | Other C-suite | 5,253 | $4.75 | $25.0K | 1 |
| 2022-01-10 | Sell | Horn Kinney | Other C-suite | 5,251 | $6.85 | $36.0K | 1 |
| 2021-12-10 | Sell | Myles David C. | Other C-suite | 10,000 | $10.30 | $103.0K | 1 |
| 2021-12-10 | Sell | Horn Kinney | Other C-suite | 5,251 | $10.39 | $54.6K | 1 |
| 2021-11-30 | Buy | BVF PARTNERS L P/IL | Director | 739,675 | $9.39 | $6.9M | 3 |
| 2021-11-29 | Sell | Harmon Cyrus | Other C-suite | 400 | $24.76 | $9.9K | 1 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Graham G. Walmsley | Director | $11.6M | $26.9M | 2024-12-17 |
| Paradigm BioCapital International Fund Ltd. | 10% owner | $1.2M | $35.8M | 2024-08-01 |
| LAMPERT MARK N | Director | $22.6M | $0 | 2023-09-12 |
| Zojwalla Naseem | Other C-suite | $0 | $8.0M | 2025-12-23 |
| CLARK IAN T | Director | $0 | $7.9M | 2025-12-19 |
| Myles David C. | Other officer | $0 | $5.6M | 2026-01-14 |
| Harmon Cyrus | Director | $0 | $4.8M | 2026-07-24 |
| Kovacs Shane William Charles | Other officer | $0 | $3.6M | 2026-01-15 |
| Bohen Sean | CEO | $0 | $1.8M | 2024-12-11 |
| Bain Capital Life Sciences Investors, LLC | 10% owner | $1.7M | $0 | 2025-01-08 |
| Mitchell Shawnte | Other C-suite | $0 | $951.5K | 2026-03-04 |
| Horn Kinney | Other C-suite | $0 | $115.5K | 2022-03-10 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
| Window | Insiders | Total | Score | 21 days vs benchmark | 63 days vs benchmark | 126 days vs benchmark | Status |
|---|---|---|---|---|---|---|---|
| 2020-11-19 → 2020-11-23 | 3 | $51.7M | 44 | -6.3% (-3.4% raw) | -31.2% (-25.2% raw) | -64.3% (-47.0% raw) | closed |
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.